ライフサイエンスコーパス: benzoyl peroxide

1 n reduction in the presence of a coreactant (benzoyl peroxide).

2 photochemical reaction between graphene and benzoyl peroxide.

3 dimethylaniline encounter interfaces bearing benzoyl peroxide.

4 Three concentrations of benzoyl peroxide (0.1, 1.5, 5.0% wt/wt) and three cumula

5 ntaining benzene 85 wt%, ethanol 14 wt%, and benzoyl peroxide 1.0 wt%; but with each at 0.018 molal c

6 mine whether repeated topical treatment with benzoyl peroxide, a source of free radicals, produced th

7 Benzoyl peroxide alone or benzoyl peroxide added after irradiation did not cause i

8 -HO)(B(C6F5)3)2] 4 with isobutene while with benzoyl peroxide afforded [Cp*2Fe][PhC(O)OE(C6F5)3] (E =

9 Benzoyl peroxide alone or benzoyl peroxide added after i

10 Topical benzoyl peroxide and benzoyl peroxide/erythromycin combi

11 excited graphene transfers a hot electron to benzoyl peroxide and induces its decomposition to a phen

12 0.16 to 0.50% was observed upon addition of benzoyl peroxide as a coreactant in the above electrolyt

13 diated with ultraviolet A in the presence of benzoyl peroxide at fluences >34 J per cm2.

14 uch as retinoids (eg, tretinoin, adapalene), benzoyl peroxide, azelaic acid, and/or combinations of t

15 First-line therapies are topical retinoids, benzoyl peroxide, azelaic acid, or combinations of topic

16 Furthermore, benzoyl peroxide (BP), a commonly used antiacne drug, wa

17 uantified in the reaction of superoxide with benzoyl peroxide (BP).

18 , benzene, is a known degradation product of benzoyl peroxide (BPO) and was recently reported to form

19 region only to the reduction side and using benzoyl peroxide (BPO) as a coreactant, strong ECL of TA

20 direct annihilation but gave strong ECL with benzoyl peroxide (BPO) as a coreactant.

21 orimetric method was developed for detecting benzoyl peroxide (BPO) in wheat flour using a smartphone

22 oreactant such as tri-n-propylamine (TPA) or benzoyl peroxide (BPO), BB3 and BB4 exhibit strong ECL a

23 ial growth over 15 times lower than those of benzoyl peroxide (BPO).

24 A benzoyl peroxide concentration-dependent increase was on

25 Topical benzoyl peroxide and benzoyl peroxide/erythromycin combinations are similar i

26 important redox reaction between amines and benzoyl peroxide for the ambient production of initiatin

27 n with N-bromosuccinimide in the presence of benzoyl peroxide gave 2,4-bis(pivaloylamino)-6-bromo-5-(

28 6%) of 127 assigned topical erythromycin and benzoyl peroxide in a combined formulation plus oral pla

29 t secondary amines can be directly used with benzoyl peroxide in a one-pot procedure that proceeds vi

30 Ideally, benzoyl peroxide in combination with a topical retinoid

31 ntent, although the highest concentration of benzoyl peroxide increased epidermal thickness and glyco

32 rotected secondary amine sites, free radical benzoyl peroxide initiated polymerization, deprotection

33 vere acne, but only with a topical retinoid, benzoyl peroxide, or their combination, and ideally for

34 al placebo, 78 (60%) of 130 assigned topical benzoyl peroxide plus oral placebo, 84 (66%) of 127 assi

35 lts indicate that repeated administration of benzoyl peroxide produces skin changes in the hairless m

36 Topical therapies including benzoyl peroxide, retinoids, and antibiotics when used i

37 3%) of 131 assigned topical erythromycin and benzoyl peroxide separately plus oral placebo.

38 ycline 12.3% (0.4 to 24.2); erythromycin and benzoyl peroxide separately versus combined formulation

39 In this direct imidation approach, benzoyl peroxide serves as both the oxidant and the carb

40 To limit resistance, it is recommended that benzoyl peroxide should always be added when long-term o

41 need oral antibiotics combined with topical benzoyl peroxide to decrease antibiotic-resistant organi

42 -response slope in the presence of 40 microM benzoyl peroxide to that of irradiated controls was 4.3

43 response slopes in the presence of 40 microM benzoyl peroxide to that of irradiated controls was 4.7

44 Benzoyl peroxide treatment alone caused less marked incr

45 CI -13.3 to 10.9); combined erythromycin and benzoyl peroxide versus oxytetracycline 11.1% (-0.7 to 2

46 s combined formulation -3.5% (-15.2 to 8.2); benzoyl peroxide versus oxytetracycline 5.0% (-7.0 to 17

47 tial synergistic effect of ultraviolet B and benzoyl peroxide was below the level of detection used i

48 n 355 nm-irradiated cells in the presence of benzoyl peroxide was inhibited in a concentration-depend

49 gistic interaction between ultraviolet B and benzoyl peroxide was not found.

50 Benzoyl peroxide was the most cost-effective treatment.

51 Benzoyl peroxide was used as a lipid soluble potential r